13 Results for "

BSO

" in MedChemExpress (MCE) Product Catalog:
Products (13)

13 Results for "BSO" in MCE Product Catalog:

37
37 Publications Verification
Cat. No.: HY-106376
CAS No.: 5072-26-4
Purity:  99.67%
Synonyms: Buthionine sulfoximine; BSO
Target:  

Ferroptosis

Research Areas:  

Cancer

DL-Buthionine-(S,R)-sulfoximine is a potent inhibitor of glutamylcysteine synthetase biosynthesis.
loading...
    loading...
37
37 Publications Verification
Cat. No.: HY-106376B
Purity:  99.09%
Synonyms: Buthionine sulfoximine hydrochloride; BSO hydrochloride
Target:  

Ferroptosis

Research Areas:  

Cancer

DL-Buthionine-(S,R)-sulfoximine hydrochloride (Buthionine sulfoximine hydrochloride) is a potent inhibitor of glutamylcysteine synthetase biosynthesis.
loading...
    loading...
21
21 Cited Publications
Cat. No.: HY-106376A
CAS No.: 83730-53-4
Purity:  99.35%
Synonyms: L-Buthionine sulfoximine; L-BSO
Target:  

Ferroptosis

Research Areas:  

Cancer

L-Buthionine-(S,R)-sulfoximine is a cell-permeable, potent, fast acting and irreversible inhibitor of g-glutamylcysteine synthetase and depletes cellular glutathione levels. The IC50 value of L-Buthionine-(S,R)-sulfoximine on melanoma, breast and ovarian tumor specimens are 1.9 μM, 8.6 μM, and 29 μM, respectively.
loading...
    loading...
21
21 Cited Publications
Cat. No.: HY-106376C
Purity:  ≥98.0%
Synonyms: L-Buthionine sulfoximine hydrochloride; L-BSO hydrochloride
Target:  

Ferroptosis

Research Areas:  

Metabolic Disease Cancer

L-Buthionine-(S,R)-sulfoximine hydrochloride is a cell-permeable, potent, fast acting, orally active and irreversible inhibitor of g-glutamylcysteine synthetase and depletes cellular glutathione levels. The IC50 value of L-Buthionine-(S,R)-sulfoximine on melanoma, breast and ovarian tumor specimens are 1.9 μM, 8.6 μM, and 29 μM, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-KE7007

MCE Bsa I is a restriction enzyme for rapid DNA digestion, including plasmid, genomic DNA as well as PCR products. Isoschizomers: Eco31 I, Bso31 I, BspTN I.

loading...
    loading...
Cat. No.: HY-179561
CAS No.: 894430-68-3
Target:  

Drug Derivative

Research Areas:  

Cardiovascular Disease

ACS14 is a derivative of Aspirin (HY-14654). ACS14 reduces Buthionine Sulfoximine (BSO) (HY-106376)-induced hypertension, plasma levels of thromboxane B2, 8-isoprostane, and insulin in rats, while GSH remained in the control range. ACS14 can be used for hypertension research .
loading...
    loading...
Cat. No.: HY-162886
Research Areas:  

Cancer

BSO-07 is a ROS/JNK activator with significant anticancer effects, having an IC50 value of 24.81 μM against human breast cancer (BC) cells. BSO-07 induces apoptosis (Apoptosis) and paraptosis by activating JNK and increasing ROS levels, including enhancing the expression of apoptosis-associated proteins such as PARP, Bax, phosphorylated p53, ATF4, and CHOP, while decreasing the levels of anti-apoptotic proteins like Bcl-2, Bcl-xL, and Survivin. BSO-07 holds promise for research in the field of breast cancer .
loading...
    loading...
Cat. No.: HY-106376BR
Synonyms: Buthionine sulfoximine hydrochloride (Standard); BSO hydrochloride (Standard)
Research Areas:  

Cancer

DL-Buthionine-(S,R)-sulfoximine (hydrochloride) (Standard) is the analytical standard of DL-Buthionine-(S,R)-sulfoximine (hydrochloride). This product is intended for research and analytical applications. DL-Buthionine-(S,R)-sulfoximine hydrochloride (Buthionine sulfoximine hydrochloride) is a potent inhibitor of glutamylcysteine synthetase biosynthesis.
loading...
    loading...
Cat. No.: HY-106376R
CAS No.: 5072-26-4
Synonyms: Buthionine sulfoximine (Standard); BSO (Standard)
Research Areas:  

Cancer

DL-Buthionine-(S,R)-sulfoximine (Standard) is the analytical standard of DL-Buthionine-(S,R)-sulfoximine. This product is intended for research and analytical applications. DL-Buthionine-(S,R)-sulfoximine is a potent inhibitor of glutamylcysteine synthetase biosynthesis.
loading...
    loading...
Cat. No.: HY-158740
CAS No.: 2644636-20-2
Target:  

Ferroptosis

Research Areas:  

Neurological Disease

1(R)-(Trifluoromethyl)oleyl alcohol (compound (R)-24) is a trifluoromethyl alcohol derivative of Oleic acid (HY-N1446) with activity in multiple models of Friedreich ataxia (FRDA). 1(R)-(Trifluoromethyl)oleyl alcohol inhibits ferroptosis induced by Erastin (HY-15763) and decreases lipid peroxidation in NBT human myoblasts with frataxin (FXN) siRNA knockdown. 1(R)-(Trifluoromethyl)oleyl alcohol at 40 μM increases survival to 95% in a model of FRDA where a significant percentage of cell death is caused by FAC (HY-B1645) and BSO (HY-106376) .
loading...
    loading...
Cat. No.: HY-184361
CAS No.: 143202-57-7
Synonyms: Ethyl 20:4BSO
Juniperonic acid ethyl ester (Ethyl 20:4BSO) is an orally active non-methylene-interrupted ω-3 polyunsaturated fatty acid ethyl ester. Juniperonic acid ethyl ester exists in Platycladus orientalis seed oil. Juniperonic acid ethyl ester reduces the ratio of 20:3n-9 to arachidonic acid in hepatic phosphatidylcholine of rats with essential fatty acid deficiency. Juniperonic acid ethyl ester is applicable to the research of hypertension and hepatic reperfusion injury .
loading...
    loading...
Cat. No.: HY-106376AR
CAS No.: 83730-53-4
Synonyms: L-Buthionine sulfoximine (Standard); L-BSO (Standard)
Research Areas:  

Cancer

L-Buthionine-(S,R)-sulfoximine (Standard) is the analytical standard of L-Buthionine-(S,R)-sulfoximine (HY-106376A). This product is intended for research and analytical applications. L-Buthionine-(S,R)-sulfoximine is a cell-permeable, potent, fast acting and irreversible inhibitor of g-glutamylcysteine synthetase and depletes cellular glutathione levels. The IC50 value of L-Buthionine-(S,R)-sulfoximine on melanoma, breast and ovarian tumor specimens are 1.9 μM, 8.6 μM, and 29 μM, respectively.
loading...
    loading...
Cat. No.: HY-183406
CAS No.: 102616-62-6
Research Areas:  

Neurological Disease Cancer

AS15 is a PDIA1 inhibitor with an IC50 value of 300 nM. AS15 interacts with the active-site cysteine of PDIA1, and this process is independent of the substrate-binding domain of PDIA1. AS15 acts as a synergistic cell growth inhibitor with buthionine sulfoximine (BSO) (HY-106376), a glutathione synthesis inhibitor. AS15 can be used in the research of glioblastoma .
loading...
    loading...
  • 1